For veterinary professionals

A personalized neoantigen vaccine, designed from your patient's own tumor.

We are a design service, not a treatment provider. We read a dog's tumor DNA, identify the mutations their immune system can recognize, and produce a vaccine design for your review. You retain every clinical decision, and administration happens only through the licensed veterinarian caring for the patient.

Refer a patient for review → The science

Where this program honestly stands

• This is an experimental research program. No product is licensed or available for sale, and we make no claim of efficacy.
• Any vaccine would be administered only by the patient's own licensed veterinarian, and only after the required USDA-APHIS (CVB) and state authorizations are in place.
• We do not treat patients, dispense, or practice veterinary medicine. Standard of care is never interrupted.
• Referring a case registers research interest for review. It is not enrollment, and it is not a request for treatment.

What we do

1 · Sequence. Tumor DNA against a matched normal (blood), so only somatic mutations are considered — inherited variants are subtracted out.
2 · Identify targets. Somatic missense variants are translated into candidate neoantigens and ranked by predicted MHC-I presentation on the patient's DLA type.
3 · Design. Top candidates are encoded into a codon-optimized mRNA construct by deterministic software — the same inputs always produce the same design.
4 · Your review. You receive a design report and decide.

What we ask of you

Review the design report — targets with driver annotation, specimen provenance and QC, and the cited evidence behind each element.
Approve, hold, or decline. Entirely your clinical judgment. A decline ends it, with no friction.
Administer on your schedule, alongside the care plan you have already set — never in place of it.

Nothing is manufactured or administered without your sign-off.

Refer a patient

Tell us about the case and the owner. We review it for suitability for our research program and, with the owner's consent, reach out to them directly. You stay in the loop throughout.

1Your details

First name

Last name

Clinic / practice

Your role

Direct email

2Patient

Dog's name

Breed

Age (years)

3Diagnosis & treatment history

Diagnosis

Stage

Prior treatments

4Owner

Owner first name

Owner last name

Owner email

Owner phone

Country

State / Province

Location tells us which veterinary-biologics authority governs the case.

5Anything else (optional)

I confirm the owner is aware this referral is being made, understands this is an experimental research program with no guarantee of benefit, and consents to RosieVaccine contacting them directly using the details above.

We typically respond within a few business days. Prefer to talk first? Email team@rosievaccine.com.